Phase II Pilot Study of the Prednisone to Dexamethasone Switch in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients With Limited Progression on Abiraterone Plus Prednisone (SWITCH Study)

British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0123-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Pcn40 - A Retrospective Study on Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Prescribed Abiraterone Acetate + Prednisone Prior to Chemotherapy in Sweden, Norway and Denmark

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer

Journal of Urology
Urology
2018English

Mp50-20 Impact of Abiraterone Acetate in Prostate Specific Antigen Trial Update: Effect of Abiraterone Acetate and Low Dose Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients With Non-Metastatic Castration-Resistant Prostate Cancer

Journal of Urology
Urology
2016English

Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE

Cancer
Cancer ResearchOncology
2018English

Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy